Microfluidic Applications in the Pharmaceutical, Life Sciences, In-Vitro Diagnostic and Medical Device Markets Report

News provided by

Jan 30, 2014, 06:00 ET

DUBLIN, January 30, 2014 /PRNewswire/ --

Research and Markets (http://www.researchandmarkets.com/research/k4nvqp/microfluidic) has announced the addition of the "Microfluidic Applications in the Pharmaceutical, Life Sciences, In-Vitro Diagnostic and Medical Device Markets Report" report to their offering.

Research and Markets Logo. (PRNewsFoto/PR NEWSWIRE EUROPE)

(Logo: http://photos.prnewswire.com/prnh/20130307/600769 )

Facing new challenges, the healthcare industry is currently moving toward personalized medicine. In this context, the line between traditional markets (pharmaceutical and in vitro diagnostic markets) has blurred. More than ever, rapid, accurate tests are needed to increase pharmaceutical research yield and better monitor/cure patients.

By offering innovative solutions, microfluidic technologies have successfully managed to fill the gap. This new Yole Développement report provides a complete analysis of microfluidic device markets and technologies. Based on an accurate investigation of the last three years' events, this report consolidates market data from 2010-2012 and provides forecasts for 2013-2018.

Microfluidic devices can be produced either by pure microfluidics fabs or in-house by fully integrated players. After revealing the top 15 pure microfluidic fab players, the report looks at the hidden market linked to in-house production.

These microfluidic devices can either be used directly for some applications (analytical devices, flow chemistry, etc.) or must be completed by reagents/biological content. The distinction between the microfluidic device market (first-level package device) and the microfluidic technologybased test market has also been calculated.

Discover the microfluidic market's complex organization, broken down in nine segments

Today, microfluidic devices are widely accepted in several applications. Nevertheless, the advantages and motivations for adopting microfluidic technologies are highly-dependent on the targeted application. For example, the added value of microfluidic devices in Point-of-Care applications depends on the associated small volume of necessary reagents, low-cost disposables and high sensibility. Contrarily, the advantages for pharmaceutical research applications are to allow process automation and multiplexed assays.

Each application is presented with market data, trends/drivers, key players and technologies used.

Recent changes in the material mix provide new opportunities for polymer and silicon

Different materials are used to manufacture microfluidic devices: glass, polymer, silicon, metal and ceramics. Whereas polymer is becoming the reference substrate for Point-Of-Care applications, glass is still the main substrate for analytical devices.
The penetration rate of each substrate vs. Microfluidic application is presented in this report.

Material mix changes present exciting opportunities for new players entering the microfluidic market. For example, the high growth rate of next-generation sequencing technologies is opening new doors for silicon players.

This report provides an analysis of these new opportunities, in line with material mix changes.

Key Topics Covered:

1. Executive summary

2. Introduction

3. What's Happened Since 2011

4. Microfluidic Markets: 2011-2018

5. Microfluidic applications

6. Materials mix analysis

7. Microfluidic product description

8. Emerging application

9. Microfluidic technologies

10. Microfluidics value chain

11. Microfluidics supply chain

12. Summary and conclusions